What Is Arcturus Therapeutics Holdings (ARCT) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Arcturus Therapeutics Holdings 's intrinsic value is estimated at a composite fair value of $7.96. While the stock appears modestly undervalued at $6.71 (implied upside of +18.6%), our analysis suggests a thinner margin of safety across 7 of 10 bullish models. Notably, First Chicago sees the most upside at +59.2% (fair value: $10.68), while ML-RIV is the most conservative at -70.9% ($1.95). The spread between these extremes — +130.1% — reveals how different analytical frameworks can reach starkly different conclusions.
What Do the Models Say About ARCT?
10 of 13 models are currently active for ARCT. Of these, 7 models suggest upside while 3 models suggest overvaluation. The Bayesian DCF estimates ARCT's intrinsic value at $4.43, implying -33.9% downside from the current price. See which stocks rank higher →
How Does ARCT Rank in Biotechnology?
Among 62 Biotechnology stocks, ARCT ranks #6 by Quality of Company score. CirclFi's QOC score of 7.0/10 evaluates 32 fundamental signals. A score of 7.0 indicates above-average quality.
See all Most Undervalued Biotechnology Stocks →
The Biotechnology sector introduces analytical considerations specific to life sciences company businesses. For Arcturus Therapeutics Holdings , metrics like market exclusivity window provide important context that general-purpose valuation models may underweight.
Is ARCT a Value Trap?
CirclFi's Value Trap algorithm assigns ARCT a score of 12/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
10 of 13 models are active for Arcturus Therapeutics Holdings . Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi Deep Alpha Valuation Engine, Arcturus Therapeutics Holdings scores 7.0 out of 10 on our 32-signal quality assessment, a solid rating that maintains reasonable quality metrics with some areas for improvement. The QOC score synthesizes profitability margins, revenue growth reliability, debt management, and capital allocation into a single metric designed to separate durable businesses from statistically cheap ones.
The gap between the most bullish and bearish model spans +130.1% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every ARCT valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across ARCT's 10 active models, average confidence is 31%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad